Comparison of tumor-derived total RNA and cell lysate on antitumor immune activity
Tumor-derived total RNA (TdRNA) and cell lysate (TCL), with almost all the relevant tumor antigens, represent attractive alternative sources of antigens in antitumor immunotherapy. However, the comparison of their capacity to elicit immune responses against breast cancer is still lacking. In this st...
Main Authors: | Qi Chen, Yipeng Jin, Xinqiu Li, Peihua Zhang, Wanbing Pan, Di Zhang, Degui Lin, Wen Chen, Jiahao Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223001658 |
Similar Items
-
Activation of Cellular Players in Adaptive Immunity via Exogenous Delivery of Tumor Cell Lysates
by: Jihyun Seong, et al.
Published: (2022-06-01) -
CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro
by: Farid Ghorbaninezhad, et al.
Published: (2022-08-01) -
Interferon-α-Induced Dendritic Cells Generated with Human Platelet Lysate Exhibit Elevated Antigen Presenting Ability to Cytotoxic T Lymphocytes
by: Ippei Date, et al.
Published: (2020-12-01) -
Efficient Colon Cancer Immunogene Therapy Through Co-Delivery of IL-22BP mRNA and Tumor Cell Lysate by CLSV Nanoparticles
by: Huang J, et al.
Published: (2023-12-01) -
Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials
by: Daphne W. Dumoulin, et al.
Published: (2021-05-01)